PhD Student/Researcher
Rutgers, The State University of New Jersey, USA
Simav Gildiz obtained BS in Biological Sciences from University of Durham, UK currently pursuing a PhD in Pharmaceutical Sciences from Rutgers University, USA. Her PhD thesis is focused on the therapeutic mRNA vaccine treatments for ovarian high grade serous carcinomas.